Saturday 17 October 2026 Export PTGX’s income statement to Excel — free account

Protagonist Therapeutics, Inc.

Protagonist Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $46.0 million, down 89.4% from fiscal 2024. In the quarter to June 2026, revenue grew 3,749.2%, EPS grew 549.1% and free cash flow grew 839.7%, each against the same quarter a year earlier.

128.75 7.80 −5.71%

Follow PTGX

Alert me

Market cap: $8.8B
P/E: 106×
Fwd P/E: 25.0×
Dividend yield: —
F-score: 4/9
Altman Z: 61.55
Beneish M: −7.18
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	88.57	0.00	0.00	100.48
P/S ratio Full definition →		20.25	120.66	92.63	28.66
P/FCF ratio Full definition →		66.49	99.01	0.00	61.90
P/Operating CF Full definition →		(2,187.08)	(150.17)	(140.17)	36.90
P/B ratio Full definition →		6.56	9.03	10.47	9.60
Price to Tangible BV Full definition →		6.56	9.03	10.47	9.60
EV/Sales Full definition →		17.54	108.55	85.36	25.92
EV/EBITDA Full definition →		281.36	0.00	0.00	129.65
EV/Operating CF Full definition →		56.06	86.61	(54.21)	55.72
EV/FCF Full definition →		57.60	89.07	(53.63)	55.98
Quick Ratio Full definition →		12.83	12.49	17.41	21.41
Current Ratio Full definition →		13.05	12.71	17.76	21.71
Net Debt/EBITDA Full definition →		12.39	11.13	143.14	(4.96)
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.32	0.07	0.10	0.35
Operating CF/Net income Full definition →		0.05	0.83	(12.94)	1.35
Capex/Depreciation Full definition →		1.10	0.23	1.20	0.15
Research and Development Expense of Revenue Full definition →		848.96%	623.34%	82.92%	19.70%
Selling, General and Administrative Expense of Revenue Full definition →		236.21%	153.74%	23.55%	5.92%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		224.09%	143.89%	25.76%	6.58%
Graham Net Nets Full definition →		0.13	0.09	0.08	0.09
Graham Number Full definition →		13.07	0.00	0.00	18.72
Earnings Yield Full definition →		1.13%	(2.35%)	(1.71%)	1.00%
Free Cash Flow Yield Full definition →		1.50%	1.01%	(1.72%)	1.62%
Revenue per Share Full definition →		0.07	0.12	0.87	3.24
Operating CF per Share Full definition →		(0.03)	(0.58)	(0.75)	3.32
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(0.03)	(0.58)	(0.76)	3.32
Cash per Share Full definition →		9.03	8.92	8.42	11.87
Shareholders Equity per Share Full definition →		10.12	9.67	10.07	12.76
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		10.12	9.67	10.07	12.76
Free Cash Flow Full definition →		(2.02)	(37.12)	(49.16)	218.88
Working Capital Full definition →		541.48	532.13	578.91	769.97
Capital Expenditures Full definition →		(0.09)	(0.14)	(0.21)	(0.17)
Net Current Asset Value Full definition →		530.17	524.09	571.47	763.15
EV/EBIT Full definition →		193.08	0.00	0.00	125.29
Capex to Sales Full definition →		0.02	0.02	0.00	0.00
Price to Operating Income Full definition →		222.87	0.00	0.00	138.54
Other line items
Average Receivables Full definition →		5.29	150.08	26.85	89.21
Average Payables Full definition →		4.35	3.48	5.68	3.35
Average Assets Full definition →		652.77	706.46	719.80	801.78
Average Common Equity Full definition →		588.68	645.00	672.26	754.78

Fold the line items

Columns are period end dates

Stockrow Weekly